{
    "title": "Viatris to settle EpiPen antitrust litigation for $264 million",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10560055/Viatris-settle-EpiPen-antitrust-litigation-264-million.html",
    "date": "2022-02-28",
    "keywords": [
        "mylan",
        "settlement",
        "teva",
        "litigation",
        "pfizer",
        "raymond",
        "drugmaker",
        "monday",
        "lawsuit",
        "competition",
        "price",
        "drug",
        "case",
        "year",
        "patent",
        "release",
        "version",
        "class",
        "action",
        "scheme",
        "allergy",
        "treatment",
        "outrage",
        "decision",
        "list",
        "pair",
        "debate",
        "behalf",
        "trial",
        "month",
        "sum",
        "state",
        "epipen",
        "conduct",
        "monopoly",
        "market",
        "district",
        "judge",
        "daniel",
        "crabtree",
        "city",
        "kansas",
        "claim",
        "viatris",
        "court",
        "approval",
        "admission",
        "liability",
        "payfordelay",
        "fear",
        "part",
        "brand",
        "name",
        "medication",
        "defendant",
        "biocon",
        "ltd",
        "deal",
        "business",
        "reporting",
        "boston",
        "mishra",
        "bengaluru",
        "editing",
        "aditya",
        "soni"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}